James Healy, Director at Bolt Biotherapeutics, Inc. (BOLT), bought 1,554,209 shares at $20.00 ($9.0M) on 2021-02-09, disclosed to the SEC on 2021-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,104,209 | $0 | 0.0% |
| 2 | $20.00 | 450,000 | $9.0M | 100.0% |
| Total | $5.79 avg | 1,554,209 | $9.0M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |